Advanced in Measles
Advanced in Measles
UK Field Epidemiology Training Programme, 
London, ENG, GB 

Overview

Sooria Balasegaram practices in London, United Kingdom. Balasegaram is rated as an Advanced expert by MediFind in the treatment of Measles. Their top areas of expertise are Salmonella Enterocolitis, Scarlet Fever, Measles, and Streptococcal Group A Infection.

Their clinical research consists of co-authoring 97 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Measles.

Locations

UK Field Epidemiology Training Programme, London, ENG, United Kingdom
Other Locations
Field Service East Of England, Cambridge, ENG, United Kingdom
Field Services North West, Liverpool, ENG L13DS, United Kingdom
United Kingdom
Salisbury, ENG, United Kingdom
Field Service, Public Health England, Bristol, ENG BS16EH, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Balasegaram's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile